ImmunoPrecise Antibodies Ltd. Annual Research And Development Expense in CAD from 2019 to 2022

Taxonomy & unit
ifrs-full: CAD
Summary
ImmunoPrecise Antibodies Ltd. quarterly/annual Research And Development Expense history and growth rate from 2019 to 2022.
  • ImmunoPrecise Antibodies Ltd. Research And Development Expense for the quarter ending January 31, 2024 was CA$1M, a 36% decline year-over-year.
  • ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2022 was CA$12.3M, a 60.3% increase from 2021.
  • ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2021 was CA$7.66M, a 288% increase from 2020.
  • ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2020 was CA$1.97M, a 343% increase from 2019.
Research And Development Expense, Annual (CAD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 12.3M +4.62M +60.3% May 1, 2022 Apr 30, 2023 40-F 2023-07-10
2021 7.66M +5.69M +288% May 1, 2021 Apr 30, 2022 40-F 2023-07-10
2020 1.97M +1.53M +343% May 1, 2020 Apr 30, 2021 40-F 2022-07-29
2019 446K May 1, 2019 Apr 30, 2020 40-F/A 2021-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.